Summary
doi: 10.25005/2074-0581-2010-12-3-78-85
Clinical performance of Interal aerosol formulation in acute respiratory viral infection
Clinical performance of interferon alfa2beta aerosol formulation (Interal) in 240 patients with acute respiratory viral infection (ARVI) was studied.
It was observed reliable relief of general and local intoxication manifestation and systemic inflammation syndrome during clinical finding of acute respiratory viral infection evolution assessment, which, in turn, precipitates recovery of patients.
The most apparent clinical performance of Interal aerosol formulation in acute respiratory viral infection was noted in working age people 20 to 40 years old.
Keywords: acute respiratory viral infection , Interferon alfa2a, Interal, ARVI .
Materials on the topic:
- Surgical treatment of idiopathik scared stenose of trachea
- Clinical - immunological disorders in urogenital chlamydiosis in men
- Evaluation of medication «Corvitin» in complex treatment of patients with acute myocardial infarction
- Prevalence of liver cirrhosis in Tajikistan
- Results of therapy patients in acute stage of HIV infection among prisoners
- Analysis of pregnant women morbidity, such as research microelement status of women's population living in districts of town Lipetsk with different atnropotehnogenic load
- Hormonal and metabolic concept of pathogenesis prostate diseases
- MEDICINES INFLUENCING ON REGENERATION OF PERIPHERIAL NERVES
- ABDOMINOPLASTICS IN PATIENTS WITH POSTOPERATING SCARS OF FRONT ABDOMENWALL
- PROCESS OF RECANALIZATION IN YEARLY PERIOD AFTER ACUTE TROMBOPHLEBITIS OF DEEP VEINS OF LOW EXTREMITIS